Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVO – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $9.27 and traded as high as $10.00. ZIVO Bioscience shares last traded at $10.00, with a volume of 167 shares trading hands.
ZIVO Bioscience Price Performance
The stock has a market capitalization of $40 million, a price-to-earnings ratio of -2.05 and a beta of 0.19. The business has a 50 day simple moving average of $9.27 and a 200-day simple moving average of $12.04.
ZIVO Bioscience Company Profile
ZIVO Bioscience is a clinical-stage biotechnology company focused on developing precision live biotherapeutics to prevent and treat gastrointestinal infections in both animal and human health markets. The company applies synthetic biology, microbiology and fermentation technologies to engineer proprietary bacterial strains that produce targeted lactic acid and antimicrobial compounds. Its pipeline includes ZB-01, an orally administered therapy for recurrent Clostridioides difficile infections in humans, and ZB-02, a feed-additive candidate aimed at reducing Salmonella colonization in poultry.
Founded in 2016 and headquartered in Carlsbad, California, ZIVO Bioscience leverages exclusive licensing agreements with academic institutions to advance its lead programs through preclinical and early clinical development.
Read More
- Five stocks we like better than ZIVO Bioscience
- Unlocked: Elon Musk’s Next Big IPO
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What Expenses Can Be Deducted From Capital Gains Tax This Year?
- The gold chart Wall Street is terrified of…
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
